Home › Drug Codes › J Codes › J9098 · CYTARABINE LIPOSOME
Updated July 1st, 2026

CYTARABINE LIPOSOME J Code: J9098

Injection, cytarabine liposome, 10 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
—
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, cytarabine liposome, 10 mg
HCPCS Added Date January 1, 2004
Route of Administration Intrathecal
Generic Status HCPCS Discontinued

About CYTARABINE LIPOSOME

Cytarabine Liposome is a medication aligned to the HCPCS J Code: J9098 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intrathecal route.

Manufacturers, reach out to us to add more information.

NDC Code Information

No NDC packages are aligned to J9098 in publicly available CMS files.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
No public NDC alignments
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CYTARABINE LIPOSOME CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96450 Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture
Not on the CMS JW / JZ list

CMS does not include Cytarabine Liposome (J9098) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9098. Wastage billing guide →

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available cytarabine liposome billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for cytarabine liposome. Please reach out to us if this is a mistake.
Are there any available cytarabine liposome patient assistance programs?
Our team has not identified a source of patient assistance information for cytarabine liposome. Please reach out to us if this is a mistake.
Where can I find cytarabine liposome prescribing information?
No available source of prescribing information for cytarabine liposome
Where can I find cytarabine liposome side effect information?
A link for cytarabine liposome side effect information is not available.
Does billing cytarabine liposome require JZ/JW wastage modifiers?
CMS does not include CYTARABINE LIPOSOME (J9098) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9098. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to CYTARABINE LIPOSOME.

C9142AlymsysInjection, bevacizumab-maly, biosimilar, (alymsys), 10 mgAmneal BiosciencesAdded October 1, 2022C9146ELAHEREInjection, mirvetuximab soravtansine-gynx, 1 mgImmunogenAdded April 1, 2023C9147IMJUDOInjection, tremelimumab-actl, 1 mgAstrazenecaAdded April 1, 2023C9148TECVAYLIInjection, teclistamab-cqyv, 0.5 mgJanssenAdded April 1, 2023C9155EPKINLYInjection, epcoritamab-bysp, 0.16 mgGenmabAdded October 1, 2023C9163TALVEYInjection, talquetamab-tgvs, 0.25 mgJanssenAdded January 1, 2024C9165ELREXFIOInjection, elranatamab-bcmm, 1 mgPfizerAdded January 1, 2024C9169ANKTIVAInjection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramAltor BioScience, LLCAdded October 1, 2024C9170IMDELLTRAInjection, tarlatamab-dlle, 1 mgAmgenAdded October 1, 2024C9173NYPOZIInjection, filgrastim-txid (nypozi), biosimilar, 1 microgramTanvex Biopharma USAAdded January 1, 2025